Zhou FL - Search Results

1

A DREAM Challenge to Build Prediction Models for Short-Term Discontinuation of Docetaxel in Metastatic Castration-Resistant Prostate Cancer.

Seyednasrollah F, Koestler DC, Wang T, Piccolo SR, Vega R, Greiner R, Fuchs C, Gofer E, Kumar L, Wolfinger RD, Kanigel Winner K, Bare C, Neto EC, Yu T, Shen L, Abdallah K, Norman T, Stolovitzky G, Soule HR, Sweeney CJ, Ryan CJ, Scher HI, Sartor O, Elo LL, Zhou FL, Guinney J, Costello JC; Prostate Cancer DREAM Challenge Community. Seyednasrollah F, et al. Among authors: zhou fl. JCO Clin Cancer Inform. 2017 Nov;1:1-15. doi: 10.1200/CCI.17.00018. JCO Clin Cancer Inform. 2017. PMID: 30657384 Free PMC article.

2

Prediction of overall survival for patients with metastatic castration-resistant prostate cancer: development of a prognostic model through a crowdsourced challenge with open clinical trial data.

Guinney J, Wang T, Laajala TD, Winner KK, Bare JC, Neto EC, Khan SA, Peddinti G, Airola A, Pahikkala T, Mirtti T, Yu T, Bot BM, Shen L, Abdallah K, Norman T, Friend S, Stolovitzky G, Soule H, Sweeney CJ, Ryan CJ, Scher HI, Sartor O, Xie Y, Aittokallio T, Zhou FL, Costello JC; Prostate Cancer Challenge DREAM Community. Guinney J, et al. Among authors: zhou fl. Lancet Oncol. 2017 Jan;18(1):132-142. doi: 10.1016/S1470-2045(16)30560-5. Epub 2016 Nov 16. Lancet Oncol. 2017. PMID: 27864015 Free PMC article. Clinical Trial.

3

Development and Validation of a Nomogram Prognostic Model for Patients With Advanced Non-Small-Cell Lung Cancer.

Wang T, Lu R, Lai S, Schiller JH, Zhou FL, Ci B, Wang S, Gao X, Yao B, Gerber DE, Johnson DH, Xiao G, Xie Y. Wang T, et al. Among authors: zhou fl. Cancer Inform. 2019 Apr 5;18:1176935119837547. doi: 10.1177/1176935119837547. eCollection 2019. Cancer Inform. 2019. PMID: 31057324 Free PMC article.

4

Relationship between treatment persistence and A1C trends among patients with type 2 diabetes newly initiating basal insulin.

Zhou FL, Xie L, Pan C, Wang Y, Vaidya N, Ye F, Preblick R, Meneghini L. Zhou FL, et al. Diabetes Obes Metab. 2018 May;20(5):1298-1301. doi: 10.1111/dom.13200. Epub 2018 Jan 28. Diabetes Obes Metab. 2018. PMID: 29278460 Free PMC article.

5

Real-world evidence concerning clinical and economic outcomes of switching to insulin glargine 300 units/mL vs other basal insulins in patients with type 2 diabetes using basal insulin.

Zhou FL, Ye F, Berhanu P, Gupta VE, Gupta RA, Sung J, Westerbacka J, Bailey TS, Blonde L. Zhou FL, et al. Diabetes Obes Metab. 2018 May;20(5):1293-1297. doi: 10.1111/dom.13199. Epub 2018 Jan 24. Diabetes Obes Metab. 2018. PMID: 29272064 Free PMC article.

6

Predictive Modeling of Hypoglycemia Risk with Basal Insulin Use in Type 2 Diabetes: Use of Machine Learning in the LIGHTNING Study.

Bosnyak Z, Zhou FL, Jimenez J, Berria R. Bosnyak Z, et al. Among authors: zhou fl. Diabetes Ther. 2019 Apr;10(2):605-615. doi: 10.1007/s13300-019-0567-9. Epub 2019 Feb 14. Diabetes Ther. 2019. PMID: 30767172 Free PMC article.

7

Real-world persistence, adherence, health care resource utilization, and costs in people with type 2 diabetes switching from a first-generation basal insulin to a second-generation (insulin glargine 300 U/mL) vs an alternative first-generation basal insulin.

Wright EE Jr, Malone DC, Trujillo JM, Gill J, Huse S, Li X, Zhou FL, Preblick R, Reid T. Wright EE Jr, et al. Among authors: zhou fl. J Manag Care Spec Pharm. 2022 Jun;28(6):592-603. doi: 10.18553/jmcp.2022.21436. Epub 2022 Mar 30. J Manag Care Spec Pharm. 2022. PMID: 35352995

8

Incidences of Severe Hypoglycemia and Diabetic Ketoacidosis and Prevalence of Microvascular Complications Stratified by Age and Glycemic Control in U.S. Adult Patients With Type 1 Diabetes: A Real-World Study.

Pettus JH, Zhou FL, Shepherd L, Preblick R, Hunt PR, Paranjape S, Miller KM, Edelman SV. Pettus JH, et al. Among authors: zhou fl. Diabetes Care. 2019 Dec;42(12):2220-2227. doi: 10.2337/dc19-0830. Epub 2019 Sep 23. Diabetes Care. 2019. PMID: 31548241

9

Performance assessment of different machine learning approaches in predicting diabetic ketoacidosis in adults with type 1 diabetes using electronic health records data.

Li L, Lee CC, Zhou FL, Molony C, Doder Z, Zalmover E, Sharma K, Juhaeri J, Wu C. Li L, et al. Among authors: zhou fl. Pharmacoepidemiol Drug Saf. 2021 May;30(5):610-618. doi: 10.1002/pds.5199. Epub 2021 Feb 3. Pharmacoepidemiol Drug Saf. 2021. PMID: 33480091 Free PMC article.

10

Hypoglycaemia and treatment patterns among insulin-treated patients with type 2 diabetes who switched to insulin glargine 300 units/mL versus other basal insulin in a real-world setting.

Zhou FL, Nicholls C, Xie L, Wang Y, Vaidya N, Meneghini LF. Zhou FL, et al. Endocrinol Diabetes Metab. 2019 Jun 14;2(3):e00073. doi: 10.1002/edm2.73. eCollection 2019 Jul. Endocrinol Diabetes Metab. 2019. PMID: 31294087 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

140 results

Search Page